Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced positive 12-month outcomes1 from its pivotal trial of the Neuspera SNM ...
Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results